GeneDx Long Term Debt To Capitalization from 2010 to 2024

WGSWW Stock   0.15  0.02  11.76%   
GeneDx Holdings Long Term Debt To Capitalization yearly trend continues to be fairly stable with very little volatility. Long Term Debt To Capitalization is likely to outpace its year average in 2024. During the period from 2010 to 2024, GeneDx Holdings Long Term Debt To Capitalization regression line of quarterly data had r-squared of  0.53 and coefficient of variation of (584.39). View All Fundamentals
 
Long Term Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.18769883
Current Value
0.2
Quarterly Volatility
0.09020015
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Net Interest Income of 1.2 M, Interest Income of 3.1 M or Depreciation And Amortization of 31.3 M, as well as many indicators such as Price To Sales Ratio of 0.31, Dividend Yield of 0.0 or PTB Ratio of 0.52. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Long Term Debt To Capitalization Growth Pattern

Below is the plot of the Long Term Debt To Capitalization of GeneDx Holdings Corp over the last few years. It is GeneDx Holdings' Long Term Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt To Capitalization10 Years Trend
Slightly volatile
   Long Term Debt To Capitalization   
       Timeline  

GeneDx Long Term Debt To Capitalization Regression Statistics

Arithmetic Mean(0.02)
Coefficient Of Variation(584.39)
Mean Deviation0.07
Median(0.06)
Standard Deviation0.09
Sample Variance0.01
Range0.261
R-Value0.73
Mean Square Error0
R-Squared0.53
Significance0
Slope0.01
Total Sum of Squares0.11

GeneDx Long Term Debt To Capitalization History

2024 0.2
2023 0.19
2022 0.024
2021 0.0276

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Long Term Debt To Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Long Term Debt To Capitalization 0.19  0.20 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.